Cargando…
Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough
OBJECTIVES AND METHODS: In September 2018, the government of India banned 328 fixed dose combinations (FDCs), 24 of which are combinations containing topical steroids. To assess what impact can be expected from this regulatory action, we analyzed reports of adverse drug events due to topical cortico...
Autores principales: | Jhaj, Ratinder, Asati, Dinesh Prasad, Chaudhary, Deepa, Sadasivam, Balakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641741/ https://www.ncbi.nlm.nih.gov/pubmed/34854405 http://dx.doi.org/10.4103/ijp.IJP_728_19 |
Ejemplares similares
-
Fixed-drug Eruptions: What can we Learn from a Case Series?
por: Jhaj, Ratinder, et al.
Publicado: (2018) -
Fixed drug eruption due to levocetirizine
por: Jhaj, Ratinder, et al.
Publicado: (2016) -
Black hairy tongue with a fixed dose combination of olanzapine and fluoxetine
por: Jhaj, Ratinder, et al.
Publicado: (2016) -
Inadequate pain relief for patients with trauma: A cause for concern?
por: Balakrishnan, Sadasivam, et al.
Publicado: (2013) -
Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021)